Genegeo

Genegeo Diagnostics(JiangSu) Co., LTD., a high-tech enterprise established in 2020 with its headquarters in Changzhou, Jiangsu, is dedicated to the research, development, production, and sales of clinical testing instruments and reagents. The company's core R&D team has over 20 years of industry experience and operates R&D centers in Chengdu, Nanjing, and Jiaxing. Its self-developed core product, a fully automatic hematology analyzer utilizing nucleic acid fluorescence staining and latex-enhanced immunoturbidimetry technology, can be used for early screening and diagnosis of diseases such as leukemia, malaria, and infections, reaching an internationally advanced technical level. The company owns 57 patents (including 8 invention patents), possesses independent intellectual property rights, and has comprehensive market channels and service capabilities.